Medical Devices Startups

Harvard Bioscience manufactures and supplies life science research tools and laboratory equipment for academic institutions and pharmaceutical companies. The company serves the research and development market with advanced instrumentation and solutions.

1 investor

Hausen manufactures molecular diagnostic tests for detecting HPV, respiratory pathogens, and leukemia fusion genes using real-time PCR technology for clinical and laboratory use.

1 investor

HaystackAnalytics develops clinical genomics products for diagnostic labs and hospitals to deliver accurate and personalized diagnostics. The company specializes in genomics-based infectious disease diagnostics, particularly for tuberculosis detection in India.

1 investor

Kaipu (Kepu) operates a network of medical laboratories and inspection centers across China and Hong Kong, providing clinical diagnostic testing services, including infectious disease and COVID-19 testing. The company runs facilities in numerous cities and supports government public health and epidemic response efforts.

1 investor

HBOX Therapies is a medical device company developing the MiRA system, an extracorporeal gas exchange device that oxygenates blood and removes carbon dioxide independently of the lungs as a less invasive alternative to mechanical ventilation. It targets patients with acute respiratory failure in intensive care units, using proprietary technologies including an artificial lung, a hyperbaric gas management system, and a novel blood pump.

1 investor

HCmed Innovations develops inhaled drug delivery devices, including breath-actuated and continuous mode mesh nebulizers, along with connected mobile applications for monitoring treatment adherence. It offers CDMO services covering development, clinical supply, regulatory support, and commercialization of drug-nebulizer combination devices for pharmaceutical partners.

1 investor

Head Diagnostics develops AI-driven digital tools for detecting and managing neurological diseases, including cognitive assessments and biomarker measurement devices for brain health evaluation. The company serves clinicians, healthcare systems, and patients worldwide through validated technology platforms targeting conditions like Alzheimer's, Parkinson's, and dementia.

1 investor

HEADCHECK provides a digital platform for sports organizations and teams to manage concussion protocols, monitor player health, and ensure compliance across all staff and athletes. The platform enables protocol execution, incident reporting, return-to-play management, and secure health record keeping for sports leagues, colleges, and athletic organizations.

1 investor

Headlamp Health builds Lumos AI, a platform that consolidates fragmented patient data into a longitudinal view to support care, research, and therapeutic development in precision neuroscience. It serves clinicians, researchers, and drug developers working to match patients with the right treatments.

1 investor

Healphi provides nurse-assisted teleconsultation for healthcare professionals, offering a portable teleconsultation kit with connected medical instruments, an integrated telemedicine software, and physical teleconsultation offices set up in communities. It serves French health provider groups (CPTS), nurses, and municipalities facing shortages of local doctors.

1 investor

Health in Code is a genetic diagnostics laboratory that performs full genetic studies, variant interpretation, and clinical-genetic reporting, and develops and manufactures disease diagnostic kits for specialized labs. It serves healthcare professionals and hospitals managing patients with hereditary genetic diseases, with clients in over 30 countries.

1 investor

HealtheMed provides a home-based care platform combining daily engagement, remote monitoring via Bluetooth health devices, and video visits with a dedicated care team of nurses, physicians, and therapists. It serves waiver clients (traditional or CDCS) with complex needs and works with care agencies, skilled nursing providers, hospitals, and FQHCs to support high-need populations staying stable and independent at home.

1 investor

Encompass Health is the nation's largest owner and operator of inpatient rehabilitation hospitals that partners with acute care providers to deliver post-acute rehabilitation services. The company focuses on improving patient outcomes, reducing hospital readmissions, and helping health systems optimize their inpatient rehabilitation capacity.

1 investor

HeartBeam develops a portable, cable-free ECG system centered on the credit card-sized AIMIGo device that synthesizes a 12-lead ECG for assessing arrhythmias. It pairs patient-captured recordings with cloud analysis and cardiologist review to provide clinical-grade cardiac data outside clinical settings.

1 investor

HealthTech Arkansas (HTA) helps medtech and healthtech companies from around the world enter the U.S. healthcare market by guiding U.S. strategy, arranging guaranteed hospital pilot projects and clinical trials through its coalition of clinical partners, and connecting them with U.S. investors. It runs HeartX, a virtual accelerator focused on cardiovascular technologies across digital health software, medical devices, and diagnostics, and often invests directly in participating companies.

1 investor

Kamedi GmbH makes heat it®, a smartphone-connected medical device (Class IIa) that treats itching and pain from insect bites by applying concentrated heat (about 51 °C) to the skin, controlled via a free companion app. The chemistry-free device plugs into a phone's charging port and is aimed at consumers and families for use on mosquito, horsefly, bee, and wasp stings.

1 investor

Helaxy develops next-generation sequencing (NGS) testing solutions for hospitals and clinical laboratories, making molecular diagnostics more accessible and easier to implement in routine care.

1 investor

Sunrise offers a 3-gram home sensor that provides overnight results to diagnose sleep apnea, connecting users with sleep specialists for personalized medical follow-up. It is a certified medical device for at-home sleep apnea diagnosis.

1 investor

Helsinn is a global pharmaceutical company that develops and distributes supportive care medications for patients with cancer and chronic diseases. The company operates through a combination of direct sales in the United States and commercial partnerships internationally.

1 investor

A deeptech AI company focused on advancing cytometry technology and hematology analysis applications.

1 investor

HemaSource is a tech-enabled medical supply chain distributor for plasma collection, blood centers, dialysis, and IV infusion/hydration providers, offering accredited temperature-controlled distribution across the U.S. Its ACE platform automates ordering, replenishment, inventory visibility, and demand forecasting for healthcare centers.

1 investor

Hemerion develops photonic drug-device combination therapies for treating glioblastomas and other brain tumors in clinical settings. The company combines photosensitizing drugs with innovative photonic systems designed to integrate into surgical workflows and selectively destroy tumor cells.

1 investor

Hemispherian is a clinical-stage pharmaceutical company developing small molecule drugs that target the TET2 enzyme as targeted therapies for aggressive cancers. Its lead compound GLIX1 is entering clinical development for glioblastoma, a cancer of the central nervous system.

1 investor

Hemo Group develops interventional medical devices for treating neuro-vascular diseases, including ischemic stroke, hemorrhagic stroke, and neuro access, with products such as the Afentta intracranial thrombectomy device. The company markets its devices across Europe, Asia, and the Middle East, with R&D conducted in the US.

1 investor